Clinical Nutrition Market Size, Share, Growth Report 2032

Industry Prospective:

The Clinical Nutrition Market was worth around USD 32,717.5 million in 2021 and is estimated to grow to about USD 45,887.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.8 percent over the forecast period. The report analyzes the Clinical Nutrition Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Clinical Nutrition Market.

Request Free Sample

Clinical Nutrition Market: Overview

Clinical nutrition assists in the prevention of diet-related disorders by detecting and treating diseases that affect food intake, intestinal absorption, and metabolism. The increasing prevalence of metabolic disorders, increased healthcare spending, and the development of the middle class in emerging economies are all driving the clinical nutrition industry ahead. The expanding aged population, as well as the development of therapeutic nutrition products tailored to the aging population, are projected to drive market expansion. COVID-19 infection has become a serious public health concern, and clinical nutrition plays a critical role in infection prevention and treatment of infection-related malnutrition. The rising prevalence of chronic diseases such as cancer and cardiovascular problems, malnutrition, respiratory diseases, and gastrointestinal ailments among children and adults is contributing to an increase in the demand for nutritional assistance. Furthermore, the growing demand for clinical nutrition in pediatric care is shaping up to be a promising potential for the clinical nutrition market. Clinical nutrition is vital during surgeries since it helps to reduce any harmful effects on patients while also allowing surgeons to work in a controlled environment. The clinical nutrition market is expected to rise throughout the projected period as a consequence of the increased sickness burden and surgery volume.

Covid-19 Impact

 In general, the COVID-19 outbreak and worldwide lockdown have proved detrimental to a variety of industries. The new coronavirus, on the other hand, has accelerated the growth of the clinical nutrition market. The illness also causes a loss of appetite, as well as other symptoms like anosmia dysgeusia or diarrhea, which both increase the risk of disease-related malnutrition. Patients with SARS-CoV-2 have nutritional deficiencies, necessitating the administration of therapeutic nutrition supplements. Nutritional supplements have been in high demand since the outbreak of the COVID-19 pandemic, which could boost the global clinical nutrition market growth in the next years. The demand for clinical nutrition products is increasing as a result of the ongoing COVID-19 crisis, as customers seek various immunity-boosting alternatives to avoid becoming infected with the novel coronavirus.

Clinical Nutrition Market: Driver

The growing number of people globally suffering from chronic diseases like as diabetes and cancer, together with the significant growth in the elderly population, will fuel the clinical nutrition market's expansion in the coming years. Since patients suffering from chronic disorders have a deficiency in important nutrients, the rise in chronic disorders has necessitated the use of clinical nutrition prescriptions. Furthermore, the growing obese population base as a result of poor eating habits and a lack of exercise can accelerate clinical nutrition market expansion. Elderly persons frequently lose their appetites or have digestive problems, necessitating nutrient supplementation via enteral or parenteral routes. This feature is expected to benefit the worldwide clinical nutrition industry over the next few years. Additionally, the large growth in premature births, as well as the overall high birth rate around the world, may boost the global industry. Premature death rates have decreased as a result of increased awareness and well-equipped facilities, resulting in significant market growth.

Request Free Sample

Clinical Nutrition Market: Restraint

Stringent restrictions and reimbursement concerns are projected to stymie market growth. Clinical nutrition items are classified as pharmaceuticals. As a result, producers must adhere to certain rules and regulations established by regulatory authorities such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Enteral products are similar to medications. As a result, they do need to go through extensive clinical trials for safety and efficacy approvals before they can be sold. Enteral nutrition products are subject to stringent labeling regulations, which include thorough supplement facts boxes. This is projected to limit the market's growth. Moreover, a lack of understanding of clinical nutrition in emerging nations is projected to impede market expansion.

Clinical Nutrition Market: Segmentation

The Clinical Nutrition Market is segregated based on Route of Administration, Application, and End User.

By Route of Administration, the market is categorized into Oral, Enteral, and Parenteral. The oral clinical nutrition market held the largest share during the forecast period and is expected to maintain its dominance throughout the forecast period, owing to an increase in malnourished patients with malignancy, chronic disease, and/or anorexia, as well as an increase in the incidences of chronic diseases such as cancer, gastrointestinal disorders, and metabolic disorders, all of which provide lucrative growth opportunities for the oral clinical nutrition market.

By Application, the market is classified into Cancer, Neurological Diseases, Metabolic Disorders, and Others. The cancer segment is expected to have the highest growth rate during the forecast period, owing to an increase in the number of people suffering from chronic conditions such as cancer and diabetes, as well as a growing geriatric population base, which is expected to drive the market over the forecast timeframe. The rising prevalence of chronic diseases has prompted an increase in clinical nutrition prescriptions, as patients suffering from such ailments are deficient in a number of critical nutrients. Furthermore, the growing obese population as a result of poor food habits and physical inactivity will drive business growth.

Recent Developments

• In 2021, Tata & Lyle Nutrition Centre is a new digital portal that provides quick access to authoritative information on ingredients to help food makers solve public health concerns.
• In 2020, SpermidinEVO, a wheat germ concentration with additional health advantages, was introduced by GoodMills Innovation. The wheat germ concentrate contains spermidine, a polyamine molecule found in ribosomes and living tissues that is involved in a variety of metabolic processes.

Report Scope:

Regional Landscape

During the forecast period, APAC has been the clinical nutrition industry leader, with Japan emerging as the region's top performer. The Japanese market is leading due to a growing older population and an increase in chronic diseases such as cancer and diabetes mellitus as a result of dietary changes. Increased efforts by organizations such as the Japan Society of Nutrition and Food Science (JSNFS) to improve public health and raise awareness of clinical nutrition may potentially benefit market growth in Japan over the assessment period. The clinical nutrition market in China benefits most from an increase in the number of players entering the nation and an increase in the number of cases of metabolic diseases.

North America held a significant position in the worldwide clinical nutrition market during the forecast period. The United States is presently in the lead, and the country-based market could improve its position in the next years as a result of high consumer awareness about wellness and health, as well as the growing desire to reduce considerable healthcare expenses. The region's clinical nutrition market demand is also being boosted by the region's rising birth rate. The growing senior population has resulted in a major increase in demand for home healthcare over the years, which is likely to be a primary growth booster in the coming years.

Competitive Landscape

Some of the main competitors dominating the Clinical Nutrition Market include - Abbott Laboratories, B. Braun Melsugen AG, Danone Nutricia Baxter Internatioinal Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Lonza Ltd, Nestle S.A., and Hero Nutritionals Inc.

Clinical Nutrition Market is segmented as follows:

By Route of Administration

• Oral
• Enteral
• Parenteral

By Application

• Cancer
• Neurological Diseases
• Metabolic Disorders
• Others

By End User

• Pediatric
• Adults
• Geriatic

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa